LBP antibody

Este producto es parte de LBP - Lipopolysaccharide binding protein
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
LBP antibody
category
Primary Antibodies
provider
FineTest
reference
FNab04713
tested applications
ELISA, WB

Description

Plays a role in the innate immune response. Binds to the lipid A moiety of bacterial lipopolysaccharides(LPS), a glycolipid present in the outer membrane of all Gram-negative bacteria(PubMed:7517398, PubMed:24120359). Acts as an affinity enhancer for CD14, facilitating its association with LPS. Promotes the release of cytokines in response to bacterial lipopolysaccharide(PubMed:7517398, PubMed:24120359).

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
lipopolysaccharide binding protein (LBP)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1:500-1:2000
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
53-60 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
P18428
Gene ID
3929
Alias
BPIFD2,BPI Fold Containing Family D,LPS-Binding Protein 3
Background
Antibody anti-LBP
Status
RUO
Note
Mol. Weight 53-60 kDa

Descripción

LBP is an acute-phase protein produced mainly by the liver in response to infections and inflammation It plays a crucial role in innate immunity by binding to lipopolysaccharides (LPS) from the outer membrane of Gram-negative bacteria and delivering them to CD14 and Toll-like receptor 4 (TLR4) complexes on immune cells This process triggers signaling pathways that lead to the production of pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, initiating immune defense against bacterial infections Elevated LBP levels are observed in sepsis, systemic inflammatory response syndrome (SIRS), and chronic inflammatory diseases Dysregulation of LBP contributes to endotoxemia, where excessive immune activation results in tissue damage and organ failure It is a valuable biomarker for assessing infection severity and therapeutic outcomes in sepsis and inflammatory conditions

Related Products

EB0197

Bovine LBP (Lipolysaccharide binding protein) ELISA Kit

Ver Producto
EGS0002

Goat/Sheep LBP (Lipopolysaccharide-binding protein) ELISA Kit

Ver Producto
EH1560

Human LBP (Lipopolysaccharide-binding protein) ELISA Kit

Ver Producto